• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后终末补体成分的激活作为移植肾功能延迟严重程度的标志物。

Activation of final complement components after kidney transplantation as a marker of delayed graft function severity.

作者信息

Arias-Cabrales Carlos E, Riera Marta, Pérez-Sáez María José, Gimeno Javier, Benito David, Redondo Dolores, Burballa Carla, Crespo Marta, Pascual Julio, Rodríguez Eva

机构信息

Department of Nephrology, Hospital del Mar, Barcelona, Catalunya, Spain.

Institut Hospital del Mar d'Investigacions Mèdiques, IMIM, Barcelona, Catalunya, Spain.

出版信息

Clin Kidney J. 2020 Oct 10;14(4):1190-1196. doi: 10.1093/ckj/sfaa147. eCollection 2021 Apr.

DOI:10.1093/ckj/sfaa147
PMID:33841865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8023215/
Abstract

BACKGROUND

Ischaemia-reperfusion (I/R) damage is a relevant cause of delayed graft function (DGF). Complement activation is involved in experimental I/R injury, but few data are available from kidney transplant (KT) patients. We studied the dynamics of membrane attack complex (C5b-9) as a soluble fraction (SC5b-9) and the histological deposit pattern of C3b, complement Factor H (FH) and C5b-9 in DGF patients.

METHODS

We evaluated SC5b-9 levels in 59 recipients: 38 with immediate graft function and 21 with DGF. The SC5b-9 was measured at admission for KT and 7 days after KT. DGF-kidney biopsies ( = 12) and a control group of 1-year protocol biopsies without tissue damage ( = 4) were stained for C5b-9, C3b and FH.

RESULTS

SC5b-9 increased significantly in DGF patients (Day 0: 6621 ± 2202 mAU/L versus Day 7: 9626 ± 4142  mAU/L; P = 0.006), while it remained stable in non-DGF patients. Days 0-7 increase >5% was the better cut-off associated with DGF versus non-DGF patient discrimination (sensitivity = 81%). In addition, SC5b-9 increase was related to DGF duration and worse graft function, and independently associated with DGF occurrence. SC5b-9, C3b and FH stains were observed in tubular epithelial cells basal membrane. DGF-kidney biopsies showed a more frequently high-intensity stain, a higher number of tubules with positive stain and larger perimeter of tubules with positive stains for SC5b-9, C3b and FH than control patients.

CONCLUSIONS

Both SC5b-9 levels and SC5b-9, C3b and FH deposits in tubular epithelial cells basal membrane are highly expressed in patients experiencing DGF. SC5b-9 levels increase could be useful as a marker of DGF severity.

摘要

背景

缺血再灌注(I/R)损伤是移植肾延迟功能恢复(DGF)的一个相关原因。补体激活参与实验性I/R损伤,但肾移植(KT)患者的数据较少。我们研究了膜攻击复合物(C5b-9)作为可溶性成分(SC5b-9)的动态变化以及DGF患者中C3b、补体因子H(FH)和C5b-9的组织学沉积模式。

方法

我们评估了59例受者的SC5b-9水平:38例移植肾功能立即恢复者和21例发生DGF者。在KT术前及术后7天测量SC5b-9。对DGF肾活检标本(n = 12)和一组无组织损伤的1年方案活检对照组标本(n = 4)进行C5b-9、C3b和FH染色。

结果

DGF患者的SC5b-9显著升高(第0天:6621±2202 mAU/L vs第7天:9626±4142 mAU/L;P = 0.006),而非DGF患者则保持稳定。第0 - 7天升高>5%是区分DGF与非DGF患者的更佳临界值(敏感性 = 81%)。此外,SC5b-9升高与DGF持续时间及更差的移植肾功能相关,且与DGF的发生独立相关。在肾小管上皮细胞基底膜观察到SC5b-9、C3b和FH染色。与对照组患者相比,DGF肾活检标本显示高强度染色更频繁、阳性染色的肾小管数量更多以及SC5b-9、C3b和FH阳性染色的肾小管周长更大。

结论

在发生DGF的患者中,SC5b-9水平以及肾小管上皮细胞基底膜中的SC5b-9、C3b和FH沉积均高度表达。SC5b-9水平升高可能作为DGF严重程度的一个标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8023215/ba9cbd14f253/sfaa147f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8023215/e8d956c8810e/sfaa147f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8023215/ba9cbd14f253/sfaa147f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8023215/e8d956c8810e/sfaa147f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8023215/ba9cbd14f253/sfaa147f2.jpg

相似文献

1
Activation of final complement components after kidney transplantation as a marker of delayed graft function severity.肾移植后终末补体成分的激活作为移植肾功能延迟严重程度的标志物。
Clin Kidney J. 2020 Oct 10;14(4):1190-1196. doi: 10.1093/ckj/sfaa147. eCollection 2021 Apr.
2
Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies.通过血浆可溶性 C5b-9 测量补体激活与一系列肾活检中的末端补体复合物染色比较。
Kidney Blood Press Res. 2023;48(1):220-230. doi: 10.1159/000529734. Epub 2023 Mar 14.
3
Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients.尿调理素和 sC5b-9 与肾移植受者移植失败的风险增加独立相关。
Front Immunol. 2019 Oct 24;10:2511. doi: 10.3389/fimmu.2019.02511. eCollection 2019.
4
Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?肾移植中的早期补体激活与后期移植结果相关吗?
Kidney Blood Press Res. 2018;43(5):1488-1504. doi: 10.1159/000494014. Epub 2018 Oct 4.
5
Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.尿肾损伤分子 1 和可溶性 C5b-9 在急性肾小管间质性肾炎中的诊断作用。
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F584-F592. doi: 10.1152/ajprenal.00176.2019. Epub 2019 Jul 10.
6
Expression of PBMC TLR4 in Renal Graft Recipients Who Experienced Delayed Graft Function Reflects Dynamic Balance Between Blood and Tissue Compartments and Helps Select a Problematic Patient.经历移植肾功能延迟的肾移植受者外周血单核细胞TLR4的表达反映了血液与组织区室之间的动态平衡,并有助于筛选出有问题的患者。
Transplant Proc. 2018 Jul-Aug;50(6):1744-1749. doi: 10.1016/j.transproceed.2018.02.134. Epub 2018 Mar 14.
7
A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.米罗西普(APT070)预防同种异体肾移植缺血再灌注损伤疗效的双盲随机对照研究(EMPIRIKAL):一项随机对照试验的研究方案
Trials. 2017 Jun 6;18(1):255. doi: 10.1186/s13063-017-1972-x.
8
Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions.高血压仅是慢性病理损伤肾脏移植肾功能延迟恢复及肾功能恶化的独立预测因素。
Transplantation. 2002 Feb 27;73(4):623-7. doi: 10.1097/00007890-200202270-00026.
9
Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.移植肾功能延迟恢复的 deceased-donor 肾移植受者的早期类固醇撤药。
J Am Soc Nephrol. 2020 Jan;31(1):175-185. doi: 10.1681/ASN.2019040416. Epub 2019 Dec 18.
10
Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation.速尿应激试验作为预测肾移植后延迟肾功能的生物标志物。
Nephron. 2019;141(4):236-248. doi: 10.1159/000495765. Epub 2019 Jan 11.

引用本文的文献

1
Comprehensive profiling of cell type-specific expression and distribution of complement genes in mouse and human kidneys: insights into normal physiology and response to kidney transplantations.小鼠和人类肾脏中补体基因的细胞类型特异性表达及分布的综合分析:对正常生理学及肾移植反应的见解
Ren Fail. 2025 Dec;47(1):2471568. doi: 10.1080/0886022X.2025.2471568. Epub 2025 Feb 27.
2
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
3
Complement Inhibition in Kidney Transplantation: Where Are We Now?

本文引用的文献

1
Role of Complement Activation in Allograft Inflammation.补体激活在同种异体移植炎症中的作用。
Curr Transplant Rep. 2019 Mar;6(1):52-59. doi: 10.1007/s40472-019-0224-2. Epub 2019 Jan 15.
2
Membrane Attack Complex and Factor H in Humans with Acute Kidney Injury.急性肾损伤患者的膜攻击复合物与补体因子H
Kidney Blood Press Res. 2018;43(5):1655-1665. doi: 10.1159/000494680. Epub 2018 Oct 31.
3
Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond.缺血再灌注损伤降低长期肾脏移植物存活率:机制及超越。
补体抑制在肾移植中的应用:现状如何?
BioDrugs. 2023 Jan;37(1):5-19. doi: 10.1007/s40259-022-00567-1. Epub 2022 Dec 13.
4
Pitfalls in complement analysis: A systematic literature review of assessing complement activation.补体分析的陷阱:评估补体激活的系统文献回顾。
Front Immunol. 2022 Oct 18;13:1007102. doi: 10.3389/fimmu.2022.1007102. eCollection 2022.
5
Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application.补体系统在肾移植中的作用:从动物模型到临床应用的进展。
Front Immunol. 2022 Feb 25;13:811696. doi: 10.3389/fimmu.2022.811696. eCollection 2022.
6
A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injury.一种有效的人可溶性 CR1 截断形式在肾缺血再灌注损伤的小鼠模型中具有保护作用。
Sci Rep. 2021 Nov 8;11(1):21873. doi: 10.1038/s41598-021-01423-y.
EBioMedicine. 2018 Feb;28:31-42. doi: 10.1016/j.ebiom.2018.01.025. Epub 2018 Feb 2.
4
Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.补体因子 H 可保护小鼠免于缺血性急性肾损伤,但对于控制肾小球 IgM 激活补体并非关键。
Eur J Immunol. 2018 May;48(5):791-802. doi: 10.1002/eji.201747240. Epub 2018 Feb 22.
5
Value of plasmatic membrane attack complex as a marker of severity in acute kidney injury.血浆膜攻击复合物作为急性肾损伤严重程度标志物的价值。
Biomed Res Int. 2014;2014:361065. doi: 10.1155/2014/361065. Epub 2014 May 25.
6
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.临床肾移植再灌注后末端补体复合物的急性短暂释放。
Transplantation. 2013 Mar 27;95(6):816-20. doi: 10.1097/TP.0b013e31827e31c9.
7
Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.肾移植后缺血/再灌注损伤围手术期补体活性的临床分析。
Clin J Am Soc Nephrol. 2012 Nov;7(11):1843-51. doi: 10.2215/CJN.02200312. Epub 2012 Aug 16.
8
Chronic renal allograft injury: early detection, accurate diagnosis and management.慢性肾移植损伤:早期检测、准确诊断与管理。
Transplant Rev (Orlando). 2012 Oct;26(4):280-90. doi: 10.1016/j.trre.2012.07.002. Epub 2012 Aug 17.
9
The new face of anaphylatoxins in immune regulation.免疫调节中新的过敏毒素作用模式。
Immunobiology. 2012 Feb;217(2):225-34. doi: 10.1016/j.imbio.2011.07.016. Epub 2011 Jul 23.
10
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.因子 H 与管状上皮细胞的结合限制了缺血性损伤中间质补体的激活。
Kidney Int. 2011 Jul;80(2):165-73. doi: 10.1038/ki.2011.115. Epub 2011 May 4.